Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COCOS: Corticosteroids for COVID-19–induced loss of smell
2021-004021-71Phase 4Terminated
- Sponsor
- University Medical Center Utrecht
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of prednisolone in Olfactory disorder, sponsored by University Medical Center Utrecht. Primary endpoint: Objective olfactory function (TDI score). Started Oct 2021; status: terminated.
02
Drugs
prednisolone
03
Conditions
Olfactory disorder
Beyond the preview
Go deeper on 2021-004021-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-004021-71.